NCCN Updates Clinical Practice Guideline for Multiple Myeloma
On March 15, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for multiple myeloma.
In the section for therapy for previously treated multiple myeloma, under other regimens, melphalan flufenamide/dexamethasone was added as a category 2A recommendation.—Janelle Bradley
Published at Tue, 16 Mar 2021 02:40:18 +0000